Conagra Q1 FY27: EPS Beats, But Operating Cash Flow Turns Negative on Litigation Payouts
CAG is trading near its 52-week low of $12.53 (7.3% above the low) on elevated volume (2.9× avg).
Summary
Conagra beat Q1 FY27 adjusted EPS estimates, but operating cash flow turned negative on litigation payouts, and the company flagged heightened impairment risk in its Refrigerated & Frozen unit.
Key Events · Earnings and Guidance · CAG
-
Q1 FY27 EPS Beats, Sales Dip
Adjusted EPS of $0.41 beat the $0.28 consensus by 46%; GAAP diluted EPS was $0.36 vs $0.34 a year ago. Net sales fell 1.4% to $2,595.9M.
-
Operating Cash Flow Turns Negative
Operating cash flow was -$4.2M vs +$120.6M in Q1 FY26, driven by higher cooking-spray litigation payments and lower operating profit.
-
Litigation Payments Mount
Conagra paid an additional $44.3M in Q1 FY27 for Pam cooking spray settlements, and a $22.9M final judgment in the diacetyl case is under appeal.
-
Refrigerated & Frozen Impairment Risk
The Refrigerated & Frozen reporting unit has zero excess fair value over carrying amount after fiscal 2026 write-downs, creating heightened risk of future impairments.
Analysis · CAG · Manufacturing
Conagra's Q1 FY27 adjusted EPS of $0.41 beat consensus by 46%, but the 10-Q reveals operating cash flow swung to a $4.2M use of cash from a $120.6M source a year ago, driven by higher cooking-spray litigation payments. The company also issued $500M of new 5.40% notes, repurchased $44M of stock, and disclosed that its Refrigerated & Frozen reporting unit now has zero excess fair value over carrying amount — a heightened impairment risk. Against the backdrop of the $1.92B fiscal 2026 net loss and halved dividend, the cash-flow deterioration and litigation overhang matter more than the headline EPS beat.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CAG was trading at $13.44 on NYSE in the Manufacturing sector, with a market capitalization of approximately $6.4B. The 52-week trading range was $12.53 to $20.32. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.